4//SEC Filing
Gordon Eric M 4
Accession 0001209191-09-012160
CIK 0001398161other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:08 PM ET
Size
10.6 KB
Accession
0001209191-09-012160
Insider Transaction Report
Form 4
Gordon Eric M
Director
Transactions
- Disposition from Tender
Common Stock
2009-02-25−12,599→ 0 total(indirect: See footnote.) - Disposition from Tender
Common Stock
2009-02-25−1,699,311→ 0 total(indirect: See footnote.) - Disposition from Tender
Common Stock
2009-02-25−505,998→ 0 total(indirect: See footnote.)
Footnotes (4)
- [F1]The shares were tendered in a tender offer by Boxford Subsidiary Corporation for consideration of (1) $2.00 per common share in cash, plus (2) the contractual right to receive up to an additional $4.55 per common share in contingent cash payments if specified regulatory and commercial milestones are achieved within agreed upon time periods.
- [F2]Shares held by Skyline Venture Partners III, L.P., whose General Partner is Skyline Venture Management III, LLC. John Freund and Yasunori Kaneko, as Managing Directors of Skyline Venture Management III, LLC, may be deemed to share voting and dispositive power with respect to all common stock and warrants to purchase common stock held by Skyline affiliated entities. In addition, Eric Gordon is a partner at Skyline ventures, and as such has influence in the voting and investment power of these shares, although he has no direct power. Each of Drs. Freund, Kaneko and Gordon disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any.
- [F3]Shares held by Skyline Venture Partners Qualified Purchaser Fund III, L.P., whose General Partner is Skyline Venture Management III, LLC. John Freund and Yasunori Kaneko, as Managing Directors of Skyline Venture Management III, LLC, may be deemed to share voting and dispositive power with respect to all common stock and warrants to purchase common stock held by Skyline affiliated entities. In addition, Eric Gordon is a partner at Skyline ventures, and as such has influence in the voting and investment power of these shares, although he has no direct power. Each of Drs. Freund, Kaneko and Gordon disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any.
- [F4]Shares held by Skyline Venture Partners Qualified Purchaser Fund IV, L.P., whose General Partner is Skyline Venture Management IV, LLC. John Freund and Yasunori Kaneko, as Managing Directors of Skyline Venture Management IV, LLC, may be deemed to share voting and dispositive power with respect to all common stock and warrants to purchase common stock held by Skyline affiliated entities. In addition, Eric Gordon is a partner at Skyline ventures, and as such has influence in the voting and investment power of these shares, although he has no direct power. Each of Drs. Freund, Kaneko and Gordon disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any.
Documents
Issuer
Targanta Therapeutics Corp.
CIK 0001398161
Entity typeother
Related Parties
1- filerCIK 0001413009
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:08 PM ET
- Size
- 10.6 KB